Psy Therapeutics, Inc.

Pharmaceutical company · Boston, Massachusetts, United States

Psy Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $458,385 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $6.8 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Psy Therapeutics at a glance

Typepharmaceutical company

HeadquartersBoston, Massachusetts, United States

Employees (self-reported, 2023)8

SEC CIK1788222

What does Psy Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $458,385 in total (2023). NIH funding came from the National Institute of Mental Health.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $6.8 million sold (2025).

Frequently asked questions about Psy Therapeutics

Where is Psy Therapeutics headquartered?

Psy Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Psy Therapeutics do?

Psy Therapeutics, Inc. is a pharmaceutical company.

Similar companies

Transcode Therapeutics, Inc.Boston, Massachusetts, United States
Akouos, Inc.Boston, Massachusetts, United States
Astria Therapeutics, Inc.Boston, Massachusetts, United States
Albireo Pharma, Inc.Boston, Massachusetts, United States
Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
Tango Therapeutics, Inc.Boston, Massachusetts, United States
Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences